Genomma Lab Internacional S.A.B. de C.V Cash Flow Conversion Efficiency
Genomma Lab Internacional S.A.B. de C.V cash flow conversion efficiency. Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (LABB) has a cash flow conversion efficiency ratio of -0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (MX$-229.17 Million ≈ $-13.19 Million USD) by net assets (MX$11.72 Billion ≈ $674.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Genomma Lab Internacional S.A.B. de C.V (2005–2025)
Cash flow conversion efficiency of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025. This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LABB stock price and chart for real-time trading data and today's change.
Genomma Lab Internacional S.A.B. de C.V Cash Flow Conversion Ratio Explained
Genomma Lab Internacional S.A.B. de C.V cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Genomma Lab Internacional S.A.B. de C.V Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genomma Lab Internacional S.A.B. de C.V ranked by their cash flow conversion efficiency. Also see Genomma Lab Internacional S.A.B. de C.V (LABB) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pharming Group NV
AS:PHARM
|
0.121x |
|
ASGN Inc
NYSE:ASGN
|
0.047x |
|
FAWER Automotive Parts Ltd Co
SHE:000030
|
0.028x |
|
Equital
TA:EQTL
|
0.020x |
|
BlackRock Credit Allocation Income Trust
NYSE:BTZ
|
0.029x |
|
Orient International Enterprise Ltd
SHG:600278
|
0.007x |
|
Baota Industry Co Ltd
SHE:000595
|
0.327x |
|
VIA Technologies Inc
TW:2388
|
0.028x |
Annual Cash Flow Conversion Efficiency for Genomma Lab Internacional S.A.B. de C.V (2005–2025)
The table below shows the annual cash flow conversion efficiency of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025. Review Genomma Lab Internacional S.A.B. de C.V (LABB) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | MX$11.11 Billion ≈ $639.47 Million |
MX$2.05 Billion ≈ $118.24 Million |
0.185x | -29.37% |
| 2024-12-31 | MX$11.59 Billion ≈ $666.93 Million |
MX$3.03 Billion ≈ $174.59 Million |
0.262x | +39.15% |
| 2023-12-31 | MX$9.38 Billion ≈ $539.98 Million |
MX$1.77 Billion ≈ $101.58 Million |
0.188x | -7.05% |
| 2022-12-31 | MX$10.15 Billion ≈ $584.28 Million |
MX$2.05 Billion ≈ $118.25 Million |
0.202x | +38.83% |
| 2021-12-31 | MX$10.07 Billion ≈ $579.66 Million |
MX$1.47 Billion ≈ $84.50 Million |
0.146x | -18.08% |
| 2020-12-31 | MX$9.63 Billion ≈ $554.45 Million |
MX$1.71 Billion ≈ $98.67 Million |
0.178x | +40.93% |
| 2019-12-31 | MX$7.97 Billion ≈ $458.91 Million |
MX$1.01 Billion ≈ $57.95 Million |
0.126x | -39.97% |
| 2018-12-31 | MX$7.43 Billion ≈ $427.47 Million |
MX$1.56 Billion ≈ $89.92 Million |
0.210x | +6.49% |
| 2017-12-31 | MX$7.05 Billion ≈ $405.65 Million |
MX$1.39 Billion ≈ $80.13 Million |
0.198x | -13.06% |
| 2016-12-31 | MX$6.79 Billion ≈ $390.93 Million |
MX$1.54 Billion ≈ $88.83 Million |
0.227x | +76.83% |
| 2015-12-31 | MX$9.25 Billion ≈ $532.26 Million |
MX$1.19 Billion ≈ $68.39 Million |
0.128x | +29.94% |
| 2014-12-31 | MX$10.50 Billion ≈ $604.46 Million |
MX$1.04 Billion ≈ $59.77 Million |
0.099x | -53.30% |
| 2013-12-31 | MX$8.84 Billion ≈ $508.48 Million |
MX$1.87 Billion ≈ $107.66 Million |
0.212x | +1222.65% |
| 2011-12-31 | MX$5.57 Billion ≈ $320.72 Million |
MX$89.21 Million ≈ $5.13 Million |
0.016x | -92.25% |
| 2010-12-31 | MX$4.11 Billion ≈ $236.63 Million |
MX$849.67 Million ≈ $48.90 Million |
0.207x | +63.53% |
| 2009-12-31 | MX$3.05 Billion ≈ $175.57 Million |
MX$385.52 Million ≈ $22.19 Million |
0.126x | +27.65% |
| 2008-12-31 | MX$2.31 Billion ≈ $133.06 Million |
MX$228.89 Million ≈ $13.17 Million |
0.099x | -43.72% |
| 2007-12-31 | MX$587.44 Million ≈ $33.81 Million |
MX$103.33 Million ≈ $5.95 Million |
0.176x | +59.27% |
| 2005-12-31 | MX$164.93 Million ≈ $9.49 Million |
MX$18.21 Million ≈ $1.05 Million |
0.110x | -- |
About Genomma Lab Internacional S.A.B. de C.V
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products t… Read more